FLT3 Inhibitor Treatment Improves Survival in Relapsed, Refractory AML Patients With Mutations - GenomeWeb https://t.co/8jx1PP9wxp
— IDRO (@IDROOhio) April 2, 2019
from Twitter https://twitter.com/IDROOhio
April 01, 2019 at 08:03PM
Monday, April 1, 2019
FLT3 Inhibitor Treatment Improves Survival in Relapsed, Refractory AML Patients With Mutations - GenomeWeb https://t.co/8jx1PP9wxp
from Twitter https://twitter.com/IDROOhio
April 01, 2019 at 08:03PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment